Works matching AU Nakata, Masanobu

Results: 48
    1
    2
    3
    4

    Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years.

    Published in:
    2011
    By:
    • Wada, Akinori;
    • Kobayashi, Naoki;
    • Asanuma, Shinsuke;
    • Matsuoka, Satomi;
    • Kosugi, Mizuha;
    • Fujii, Shiro;
    • Noguchi, Shinsuke;
    • Miyazono, Takayoshi;
    • Nakata, Masanobu;
    • Ota, Shuichi;
    • Imai, Kiyotoshi;
    • Hirano, Teiichi;
    • Ogasawara, Masahiro;
    • Kiyama, Yoshio;
    • Kasai, Masaharu
    Publication type:
    journal article
    5

    A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.

    Published in:
    2006
    By:
    • Mizoroki, Fumi;
    • Hirose, Yuko;
    • Sano, Masayuki;
    • Fukuda, Haruhiko;
    • Tobinai, Kensei;
    • Nakata, Masanobu;
    • Taniwaki, Masafumi;
    • Kawano, Fumio;
    • Uozumi, Kimiharu;
    • Sawada, Kenichi;
    • Fukuhara, Shiro;
    • Nasu, Kaori;
    • Ohno, Yoichiro;
    • Toki, Hironobu;
    • Togawa, Atsushi;
    • Kikuchi, Masahiro;
    • Hotta, Tomomitsu;
    • Shimoyama, Masanori;
    • Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG)
    Publication type:
    journal article
    6

    Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma.

    Published in:
    Cancer Science, 2009, v. 100, n. 10, p. 1951, doi. 10.1111/j.1349-7006.2009.01247.x
    By:
    • Tobinai, Kensei;
    • Ishizawa, Ken-ichi;
    • Ogura, Michinori;
    • Itoh, Kuniaki;
    • Morishima, Yasuo;
    • Ando, Kiyoshi;
    • Taniwaki, Masafumi;
    • Watanabe, Takashi;
    • Yamamoto, Joji;
    • Uchida, Toshiki;
    • Nakata, Masanobu;
    • Terauchi, Takashi;
    • Nawano, Shigeru;
    • Matsusako, Masaki;
    • Hayashi, Masaki;
    • Hotta, Tomomitsu
    Publication type:
    Article
    7

    Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab.

    Published in:
    Cancer Science, 2009, v. 100, n. 7, p. 1344, doi. 10.1111/j.1349-7006.2009.01162.x
    By:
    • Tobinai, Kensei;
    • Watanabe, Takashi;
    • Tanimoto, Kazuki;
    • Maruyama, Dai;
    • Nakata, Masanobu;
    • Itoh, Kuniaki;
    • Morishima, Yasuo;
    • Ogura, Michinori;
    • Usui, Noriko;
    • Kasai, Masaharu;
    • Terauchi, Takashi;
    • Nawano, Shigeru;
    • Matsusako, Masaki;
    • Matsuno, Yoshihiro;
    • Nakamura, Shigeo;
    • Mori, Shigeo;
    • Ohashi, Yasuo
    Publication type:
    Article
    8

    Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma.

    Published in:
    Cancer Science, 2008, v. 99, n. 1, p. 140, doi. 10.1111/j.1349-7006.2007.00638.x
    By:
    • Ogawa, Yoshiaki;
    • Tobinai, Kensei;
    • Ogura, Michinori;
    • Ando, Kiyoshi;
    • Tsuchiya, Takahide;
    • Kobayashi, Yukio;
    • Watanabe, Takashi;
    • Maruyama, Dai;
    • Morishima, Yasuo;
    • Kagami, Yoshitoyo;
    • Taji, Hirofumi;
    • Minami, Hironobu;
    • Itoh, Kuniaki;
    • Nakata, Masanobu;
    • Hotta, Tomomitsu
    Publication type:
    Article
    9

    Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (<sup>90</sup>Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma.

    Published in:
    Cancer Science, 2005, v. 96, n. 12, p. 903, doi. 10.1111/j.1349-7006.2005.00120.x
    By:
    • Watanabe, Takashi;
    • Terui, Shoji;
    • Itoh, Kuniaki;
    • Terauchi, Takashi;
    • Igarashi, Tadahiko;
    • Usubuchi, Noriko;
    • Nakata, Masanobu;
    • Nawano, Shigeru;
    • Sekiguchi, Naohiro;
    • Kusumoto, Shigeru;
    • Tanimoto, Kazuki;
    • Kobayashi, Yukio;
    • Endo, Keigo;
    • Seriu, Taku;
    • Hayashi, Masaki;
    • Tobinai, Kensei
    Publication type:
    Article
    10

    Extragonadal germ cell tumors in Japan.

    Published in:
    Cancer Science, 2003, v. 94, n. 12, p. 1107, doi. 10.1111/j.1349-7006.2003.tb01408.x
    By:
    • Ebi, Hiromichi;
    • Nakata, Masanobu;
    • Tahara, Makoto;
    • Igarashi, Tadahiko;
    • Kawada, Kenji;
    • Itoh, Kuniaki;
    • Ueda, Ryuzo;
    • Minami, Hironobu
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Chemotherapy in the treatment of advanced or recurrent olfactory neuroblastoma.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2006, v. 2, n. 4, p. 180, doi. 10.1111/j.1743-7563.2006.00064.x
    By:
    • YOH, Kiyotaka;
    • TAHARA, Makoto;
    • KAWADA, Kenji;
    • MUKAI, Hirofumi;
    • NAKATA, Masanobu;
    • ITOH, Kuniaki;
    • KAWASHIMA, Mitsuhiko;
    • NISHIMURA, Hideki;
    • HAYASHI, Ryuichi;
    • OGINO, Takashi;
    • MINAMI, Hironobu
    Publication type:
    Article
    30

    Association of Epstein–Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency‐associated lymphoproliferative disorders in patients with autoimmune diseases.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 799, doi. 10.1002/hon.2790
    By:
    • Fujimoto, Katsuya;
    • Hatanaka, Kanako C.;
    • Hatanaka, Yutaka;
    • Kasahara, Ikumi;
    • Yamamoto, Satoshi;
    • Tsuji, Takahiro;
    • Nakata, Masanobu;
    • Takakuwa, Yasunari;
    • Haseyama, Yoshihito;
    • Oyamada, Yumiko;
    • Yonezumi, Masakatsu;
    • Suzuki, Hiroaki;
    • Sakai, Hajime;
    • Noguchi, Hiroko;
    • Mori, Akio;
    • Nishihara, Hiroshi;
    • Teshima, Takanori;
    • Matsuno, Yoshihiro
    Publication type:
    Article
    31
    32
    33
    34

    Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.

    Published in:
    Clinical Infectious Diseases, 2015, v. 61, n. 5, p. 719, doi. 10.1093/cid/civ344
    By:
    • Shigeru Kusumoto;
    • Yasuhito Tanaka;
    • Ritsuro Suzuki;
    • Takashi Watanabe;
    • Masanobu Nakata;
    • Hirotaka Takasaki;
    • Noriyasu Fukushima;
    • Takuya Fukushima;
    • Yukiyoshi Moriuchi;
    • Kuniaki Itoh;
    • Kisato Nosaka;
    • Ilseung Choi;
    • Masashi Sawa;
    • Rumiko Okamoto;
    • Hideki Tsujimura;
    • Toshiki Uchida;
    • Sachiko Suzuki;
    • Masataka Okamoto;
    • Tsutomu Takahashi;
    • Isamu Sugiura
    Publication type:
    Article
    35
    36
    37
    38
    39

    Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 5, p. 739, doi. 10.1111/bjh.12962
    By:
    • Fukushima, Takuya;
    • Nomura, Shogo;
    • Shimoyama, Masanori;
    • Shibata, Taro;
    • Imaizumi, Yoshitaka;
    • Moriuchi, Yoshiyuki;
    • Tomoyose, Takeaki;
    • Uozumi, Kimiharu;
    • Kobayashi, Yukio;
    • Fukushima, Noriyasu;
    • Utsunomiya, Atae;
    • Tara, Mitsutoshi;
    • Nosaka, Kisato;
    • Hidaka, Michihiro;
    • Uike, Naokuni;
    • Yoshida, Shinichiro;
    • Tamura, Kazuo;
    • Ishitsuka, Kenji;
    • Kurosawa, Mitsutoshi;
    • Nakata, Masanobu
    Publication type:
    Article
    40

    Comprehensive analysis of bacteriocins in Streptococcus mutans.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92370-1
    By:
    • Watanabe, Atsuko;
    • Kawada-Matsuo, Miki;
    • Le, Mi Nguyen-Tra;
    • Hisatsune, Junzo;
    • Oogai, Yuichi;
    • Nakano, Yoshio;
    • Nakata, Masanobu;
    • Miyawaki, Shouichi;
    • Sugai, Motoyuki;
    • Komatsuzawa, Hitoshi
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48